Subject : Participation in study entitled: PERSPECTIVE ON GI MOTILITY DISORDERS: PRACTICE MANAGEMENT & LIFESTYLE MODIFICATION
Gastrointestinal motility disorders encompass a wide array of signs and symptoms that can occur anywhere throughout the luminal gastrointestinal tract. Motility disorders of the GI tract are highly prevalent in the clinical setting and are now readily diagnosed in the motility laboratory. Motility disorders are often chronic in nature and dramatically affect patients’ quality of life. These prevalent disorders cause a tremendous impact both to the individual patient and to society as a whole. Significant progress has been made over the years in understanding the etiology and pathophysiology of gastrointestinal motility disorders.
A number of new therapies are now available to treat symptoms of GI dysmotility. Many of these target the serotonin system, which has been recognized as playing a critical role in normal gut pathophysiology. The focus of management of gastrointestinal motility disorders is to improve survival and quality of life.
This cross sectional study is designed to understand the epidemiology, prevalent motility disorders and management approach to achieve the desirable therapeutic outcome in various motility disorders.
If you agree to participate, you will be required to respond to questions of the enclosed questionnaire. We trust you and we are partners in promoting safe and effective drug therapy. In that spirit we hope you will consent to participate in this study. If you do, please sign and return the enclosed reply along with your visiting card for accuracy of records.
|
}}){kind=logo}